| Date | Title | Description | Source |
| 17.04.2024 | World Hemophilia Day 2024"Equitable access for all: rec... | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community ... | en.prnasia... |
| 09.02.2022 | BioMarin lands $110m sale of priority review voucher; Hybrid... | BioMarin announced that it has sold its priority review voucher for $110 million, but it hasn’t anno... | endpts.com... |
| 09.01.2022 | BioMarin Announces Stable and Durable Annualized Bleed Contr... | SAN RAFAEL, Calif., Jan. 9, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today a... | marketscre... |
| 28.07.2021 | BioMarin Announces Second Quarter 2021 Financial Results and... | | prnewswire... |
| 21.07.2021 | BioMarin Announces Oral Presentation at International Societ... | | prnewswire... |
| 19.07.2021 | BioMarin Announces Oral Presentation of Positive One-Year Re... | | prnewswire... |
| 02.07.2021 | BioMarin Announces 12 Presentations at the International Soc... | | prnewswire... |
| 25.06.2021 | BioMarin Receives Positive CHMP Opinion in Europe for Vosori... | | prnewswire... |
| 25.06.2021 | BioMarin Pharmaceutical : Receives Positive CHMP Opinion in ... | SAN RAFAEL, Calif., June 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announ... | marketscre... |
| 12.05.2021 | BioMarin Announces 6 Presentations at American Society of Ge... | | prnewswire... |
| 29.04.2021 | BioMarin Announces First Quarter 2021 Financial Results and ... | | prnewswire... |
| 29.04.2021 | Is the Rally Ready to Begin for BioMarin Pharmaceutical? | April 29, 2021 4 min read This story originally appeared on MarketBeat
Shares of BioMarin Pharmaceut... | entreprene... |
| 15.04.2021 | BioMarin Announces New and Updated Data at 2021 American Col... | | prnewswire... |
| 20.03.2021 | BIOMARIN PHARMACEUTICAL INC.
BioMarin Pharmaceutical : Anno... | SAN RAFAEL, Calif., March 20, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today... | marketscre... |
| 20.03.2021 | BioMarin Pharmaceutical : Announces Oral Presentation at END... | SAN RAFAEL, Calif., March 20, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today... | marketscre... |
| 20.03.2021 | BioMarin Announces Oral Presentation at ENDO2021, the Endocr... | | prnewswire... |
| 08.03.2021 | BioMarin Announces FDA Regenerative Medicine Advanced Therap... | | prnewswire... |
| 03.03.2021 | BioMarin Completes Full Enrollment in Phase 2 Study of Vosor... | | prnewswire... |
| 25.02.2021 | BioMarin Announces Fourth Quarter and Record Full-year 2020 ... | | prnewswire... |
| 10.01.2021 | BioMarin Announces Positive Phase 3 Gene Therapy Trial Resul... | | prnewswire... |
| 21.12.2020 | BioMarin Announces Benefit Maintained for Over Two Years in ... | | prnewswire... |
| 05.11.2020 | BioMarin Announces Third Quarter 2020 Total Revenues of $477... | | prnewswire... |
| 02.11.2020 | Food and Drug Administration Accepts BioMarin's New Drug App... | | prnewswire... |
| 07.10.2020 | BioMarin, Pioneer in Rare Disease Treatments for Phenylketon... | | prnewswire... |
| 05.10.2020 | Scientific Luminary and MacArthur Fellowship Winner, Kevin E... | | prnewswire... |
| 02.10.2020 | BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy,... | | prnewswire... |
| 08.09.2020 | BioMarin Announces The Lancet Publishes Detailed Vosoritide ... | | prnewswire... |
| 19.08.2020 | BioMarin Receives Complete Response Letter (CRL) from FDA fo... | | prnewswire... |
| 06.05.2020 | DiNAQOR and BioMarin to develop gene theapies for rare heart... | DiNAQOR was founded in 2019 by several leading pharmaceutical and biotechnology executives academics... | startuptic... |
| 06.05.2020 | DiNAQOR and BioMarin to develop gene theapies for rare heart... | | startuptic... |
| 28.05.2019 | BioMarin to take Phase III hemophilia gene therapy data to r... | Both studies showed significant increases in Factor VIII activity, while median annual bleeding epis... | medcitynew... |
| 13.10.2016 | The compassionate use poll: A lopsided vote favors post... | We ran a snap poll yesterday on compassionate use policies, and there’s clearly plenty of po... | endpts.com... |
| 25.08.2015 | Morning Read: Hatteras Venture Partners raises $90M for fift... | PAYERS-PROVIDERS
A series of pilot programs in Ventura and Los Angeles counties are using some param... | medcitynew... |
| - | BioMarin to take Phase III hemophilia gene therapy data to r... | A company developing a gene therapy for hemophilia plans to meet with US and European regulators to ... | medcitynew... |
| - | A history of the advancements for PKU after almost two decad... | For twelve-year-old Kellen Brown, preparing for a sleepover is far more challenging than for most bo... | statnews.c... |
| - | Morning Read: Hatteras Venture Partners raises $90M for fift... | TOP STORIES
Hatteras Venture Partners has raised $90 million as part of its first close for its fift... | medcitynew... |
